Clinical Trial Update: Donidalorsen Treatment in Children With Hereditary Angioedema [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating donidalorsen for hereditary angioedema in children is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Angioedema

Drugs mentioned

• Donidalorsen (antisense oligonucleotide targeting prekallikrein)

Snippet

Sponsor: Ionis Pharmaceuticals, Inc. | Conditions: Hereditary Angioedema (HAE) | Phase 3 | Status: RECRUITING